Sale!

SLC22A12 Gene Hypouricemia Renal Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC22A12 gene plays a critical role in the regulation of uric acid levels within the body by encoding for a protein that functions as a urate transporter in the kidneys. Mutations in this gene can lead to hypouricemia renal type 1, a condition characterized by abnormally low levels of uric acid in the blood. This condition can result in various health issues, including exercise-induced acute renal failure and urolithiasis.

To diagnose this genetic condition, the SLC22A12 Gene Hypouricemia Renal Type 1 Genetic Test is available. This specialized test is designed to detect mutations in the SLC22A12 gene that are responsible for the condition. By analyzing a patient’s DNA, the test can provide crucial information for the diagnosis, management, and treatment of individuals with or at risk of developing hypouricemia renal type 1.

The test is offered at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the comprehensive analysis and expert interpretation that accompanies the service. Conducted in a state-of-the-art laboratory by experienced geneticists, the SLC22A12 Gene Hypouricemia Renal Type 1 Genetic Test is a valuable tool for patients and healthcare providers in the management of hypouricemia renal type 1.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC22A12 Gene Hypouricemia renal type 1 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Hepatology Nephrology Endocrinology Disorders

Doctor

General Physician

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test gene SLC22A12

Test Details

SLC22A12 gene hypouricemia, renal type 1 is a genetic disorder characterized by the inability of the kidneys to reabsorb uric acid, resulting in low levels of uric acid in the blood. This condition is caused by mutations in the SLC22A12 gene, which codes for a protein involved in the reabsorption of uric acid in the kidneys.

NGS (Next Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the rapid and cost-effective analysis of large amounts of genetic data. To diagnose SLC22A12 gene hypouricemia, renal type 1, an NGS genetic test can be performed. This test involves sequencing the SLC22A12 gene to identify any mutations or variations that may be present. The results of the test can help confirm the diagnosis and guide treatment decisions.

Genetic testing for SLC22A12 gene hypouricemia, renal type 1 can be particularly beneficial for individuals with a family history of the condition or those who exhibit symptoms such as low levels of uric acid in the blood and recurrent kidney stones. It can also be used for carrier testing in individuals with a family history of the condition who are planning to have children.

It is important to note that genetic testing for SLC22A12 gene hypouricemia, renal type 1 should be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide appropriate genetic counseling and help individuals understand the implications of the test results.

Test Name SLC22A12 Gene Hypouricemia renal type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test gene SLC22A12
Test Details

SLC22A12 gene hypouricemia, renal type 1 is a genetic disorder characterized by the inability of the kidneys to reabsorb uric acid, resulting in low levels of uric acid in the blood. This condition is caused by mutations in the SLC22A12 gene, which codes for a protein involved in the reabsorption of uric acid in the kidneys.

NGS (Next Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the rapid and cost-effective analysis of large amounts of genetic data.

To diagnose SLC22A12 gene hypouricemia, renal type 1, an NGS genetic test can be performed. This test involves sequencing the SLC22A12 gene to identify any mutations or variations that may be present. The results of the test can help confirm the diagnosis and guide treatment decisions.

Genetic testing for SLC22A12 gene hypouricemia, renal type 1 can be particularly beneficial for individuals with a family history of the condition or those who exhibit symptoms such as low levels of uric acid in the blood and recurrent kidney stones. It can also be used for carrier testing in individuals with a family history of the condition who are planning to have children.

It is important to note that genetic testing for SLC22A12 gene hypouricemia, renal type 1 should be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide appropriate genetic counseling and help individuals understand the implications of the test results.